UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program vs Tempus ECG-Low EF
AI Verdict
Choose UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program if…
Choose UltraExtend NX CUW-U001S V2.0 if your practice requires advanced, detailed post-processing and quantitative analysis of cardiac ultrasound images. This tool is ideal for cardiologists and cardiothoracic surgeons who need precise cardiac motion tracking, 2D/3D wall motion analysis, and robust tools for planning complex procedures like THV deployment or clipping based on 3D TEE data, all within a comprehensive offline workflow.
View UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program →Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if your primary goal is to efficiently screen and identify patients aged 40 or older who may be at risk of heart failure due to low left ventricular ejection fraction (LVEF ≤40%). This AI software is best suited for integration into general clinical diagnostic settings, including emergency medicine and internal medicine, to provide a rapid, binary output from standard 12-lead ECG recordings, aiding in early risk stratification and further evaluation.
View Tempus ECG-Low EF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program | Tempus ECG-Low EF |
|---|---|---|
| Deployment | On-premise (software application) | Integrates with current ECG platforms and electronic health records (EHRs). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Tempus ECG-Low EFTempus ECG-Low EF (Tool B) offers higher usability for a broader range of clinicians due to its seamless integration into existing healthcare facility workflows and a simple binary output, requiring minimal direct user interaction. UltraExtend NX (Tool A), while providing a complete offline workflow, implies a more dedicated application for specialists to perform detailed post-processing analysis.
Clinical Value
Tempus ECG-Low EFWhile both tools offer significant clinical value, Tempus ECG-Low EF (Tool B) provides a scalable screening tool for early identification of low LVEF from widely available ECGs, potentially impacting a larger patient population by prompting further diagnostic workup for a critical, often undiagnosed condition. UltraExtend NX (Tool A) focuses on deep, quantitative analysis for specialists and complex procedural planning.
Pricing & Value
Tempus ECG-Low EFBoth tools require direct contact for pricing, limiting transparency. However, Tempus ECG-Low EF (Tool B) explicitly confirms HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are crucial for healthcare organizations and add significant value by reducing legal and compliance uncertainties during procurement.
Enterprise Readiness
Tempus ECG-Low EFTempus ECG-Low EF (Tool B) demonstrates stronger enterprise readiness by explicitly stating HIPAA compliance and BAA availability, which are fundamental for secure healthcare data handling. Its deployment model, integrated into existing workflows via standard communication protocols, suggests easier and less resource-intensive implementation compared to UltraExtend NX's (Tool A) on-premise deployment and less explicit compliance details.
Innovation
Tempus ECG-Low EFBoth tools are innovative in their respective domains. However, Tempus ECG-Low EF (Tool B) stands out by applying AI to standard 12-lead ECGs to detect signs of low LVEF, a novel approach for population-level screening and early intervention that leverages readily available, low-cost data at scale. This has the potential for broader impact on patient care by identifying at-risk individuals earlier.
Support & Docs
TieAs FDA-cleared medical devices, both UltraExtend NX (Tool A) and Tempus ECG-Low EF (Tool B) are expected to have comprehensive documentation, including instructions for use and performance information. While specific details on ongoing support services are not explicitly provided for either tool in the available information, both companies are established in the medical field, implying standard support offerings.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program | Tempus ECG-Low EF |
|---|---|---|
| Name | UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program | Tempus ECG-Low EF |
| Company | Canon Medical Systems Corporation | Tempus AI |
| Primary Function | AI-enabled ultrasound image analysis for advanced cardiac motion tracking and measurement, facilitating offline analysis and optimizing workflow. | AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%). |
| Specialties | Cardiology, Cardiothoracic Surgery | Cardiology, Emergency Medicine, Internal Medicine |
| Input Data Analyzed | Ultrasound images (2D and 3D Wall Motion Tracking, 3D TEE data) | 12-lead ECG recordings (resting, non-ambulatory) |
| Output/Result | Precise and reproducible cardiac quantification, 2D and 3D Wall Motion Tracking, Auto EF LV, tools for planning complex procedures. | Binary output (Low LVEF Detected / Not Detected) |
| Target Patient Population | Not specified | Patients 40 years or older at risk of heart failure |
Videos
Demos, reviews, and walkthroughs featuring UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program and Tempus ECG-Low EF.
Frequently Asked Questions
More Comparisons
More matchups featuring UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program or Tempus ECG-Low EF
Backers
Who funded each tool's parent company.